Ottawa, Aug. 22, 2025 (GLOBE NEWSWIRE) — According to Precedence Research, the global over the counter (OTC) drugs market size is expected to be worth over USD 242.94 billion by 2034, up from USD 135.25 billion in 2025 and is growing at a strong CAGR of 6.72% from 2025 to 2034. The growing expansion of e-commerce, increasing popularity of self-medication, and growing healthcare expenditure drive the market growth.
Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.
Try Before You Buy – Get the Sample Report@ https://www.precedenceresearch.com/sample/1466
Over The Counter Drugs (OTC) Market Overview
Over the Counter (OTC) drugs are medications sold without a prescription from a healthcare professional to consumers. OTC drugs are used to treat minor conditions like colds, pain, headaches, fever, upset stomach, runny nose, and allergies. OTC drugs offer first-line treatments and reduce healthcare costs.
OTC drugs are widely available in convenience stores, pharmacies, online pharmacies, and grocery stores. OTC drugs are affordable and relieve symptoms of common diseases. OTC drugs are available in various formats like tablets, soft capsules, ointments, hard capsules, powder, and many more.
Over the Counter (OTC) drugs Market Key Highlights:
- In terms of revenue, the global OTC drugs market is projected to reach USD 141.86 billion in 2026.
- The North America over the counter (OTC) drugs market surpassed USD 39.77 billion in 2024.
- The Europe OTC drugs market accounted for USD 27.71 billion in 2024 and is representing a CAGR of 5.3%.
- The Asia Pacific market reached USD 52.51 billion in 20224 with a notable CAGR of 7.15%.
- By route of administration, the oral segment held the major market share of 56.66% in 2024.
- By route of administration, the parenteral segment accounted for the highest market share of 20.24% market share in 2024.
Over the Counter (OTC) Drugs Market Size Analysis (USD Million) from 2022 to 2024
OTC Drugs Market Size Analysis (USD Million) By Product 2022-2024
| Product | 2022 | 2023 | 2024 |
| Vitamin and Dietary Supplements | 58,668.36 | 61,042.45 | 63,623.01 |
| Cough and Cold Products | 16,345.25 | 16,972.87 | 17,655.23 |
| Analgesics | 14,882.98 | 15,408.28 | 15,979.84 |
| Gastrointestinal Products | 8,201.19 | 8,507.62 | 8,840.83 |
| Sleep Aids | 4,936.54 | 4,998.45 | 5,069.94 |
| Otic Products | 3,473.40 | 3,520.5 | 3,574.55 |
| Wart Removers | 3,385.12 | 3,420.5 | 3,462.40 |
| Mouth Care Products | 3,353.20 | 3,416.06 | 3,486.15 |
| Ophthalmic products | 2,534.92 | 2,524.77 | 2,519.02 |
| Botanicals | 2,271.15 | 2,269.10 | 2,270.99 |
| Smoking Cessation Products | 1,249.98 | 1,283.76 | 1,320.74 |
| Feminine Care | 1,017.06 | 1,032.97 | 1,050.95 |
| Others |